These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. I've been diagnosed with gout and told that the elevated level of uric acid that brought it about may also increase my risk of heart attack. Is this true? Duke Med Health News; 2009 May; 15(5):12. PubMed ID: 19746518 [No Abstract] [Full Text] [Related]
23. [Endocrine components in pathogenesis and clinico-metabolic evolution of dyspurinia in primary gout and its therapy]. Butturini U; Coscelli C; Palmari V Recenti Prog Med; 1971 Oct; 51(4):359-408. PubMed ID: 5172411 [No Abstract] [Full Text] [Related]
24. [Treatment of hyperuricemia and gout]. Gröbner W; Walter-Sack I Med Monatsschr Pharm; 2005 May; 28(5):159-64; quiz 165-6. PubMed ID: 15912988 [No Abstract] [Full Text] [Related]
25. [100 years of gout: from quackery and hypothesis to directed therapy]. Mertz DP Fortschr Med; 1982 Apr; 100(14):636-44. PubMed ID: 7044928 [No Abstract] [Full Text] [Related]
26. Opportunities for improving medication use and monitoring in gout. Singh JA; Hodges JS; Asch SM Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554 [TBL] [Abstract][Full Text] [Related]
27. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout. Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847 [TBL] [Abstract][Full Text] [Related]
28. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial. Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369 [TBL] [Abstract][Full Text] [Related]
29. [Nutrition in gout]. Michelsen A Med Monatsschr Pharm; 1993 Sep; 16(9):263-5. PubMed ID: 8412976 [No Abstract] [Full Text] [Related]
30. [Gout in the evolution of Von Gierke's disease]. Benedetti A; Bucciante G; Cattano G; Nardini A Minerva Med; 1969 May; 60(38):1849-59. PubMed ID: 5255205 [No Abstract] [Full Text] [Related]
31. [Gout as an unusual cause of pelvic pain]. van den Berge M; Vrugt B; Holt C; Smit CJ; Hoogenberg K Ned Tijdschr Geneeskd; 2006 Jan; 150(3):151-4. PubMed ID: 16463619 [TBL] [Abstract][Full Text] [Related]
33. Gout. A painful joint disorder. Mayo Clin Health Lett; 2001 Nov; 19(11):1-3. PubMed ID: 11692625 [No Abstract] [Full Text] [Related]
34. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. Dalbeth N; Kumar S; Stamp L; Gow P J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857 [TBL] [Abstract][Full Text] [Related]
35. [Therapy of gout and hyperuricemia]. Pauri A Clin Ter; 1983 Dec; 107(5):417-24. PubMed ID: 6661890 [No Abstract] [Full Text] [Related]
36. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol. Reinders MK; van Roon EN; Jansen TL; Delsing J; Griep EN; Hoekstra M; van de Laar MA; Brouwers JR Ann Rheum Dis; 2009 Jan; 68(1):51-6. PubMed ID: 18250112 [TBL] [Abstract][Full Text] [Related]